Literature DB >> 28673872

Bowel Preparation Improves the Accuracy of Transvaginal Ultrasound in the Diagnosis of Rectosigmoid Deep Infiltrating Endometriosis: A Prospective Study.

Cristina Ros1, María José Martínez-Serrano2, Mariona Rius2, Mauricio Simoes Abrao3, Jordina Munrós2, Ma Ángeles Martínez-Zamora2, Meritxell Gracia2, Francisco Carmona2.   

Abstract

STUDY
OBJECTIVE: To compare the accuracy of transvaginal ultrasound (TVUS) with and without bowel preparation (BP) to detect and describe intestinal nodules of deep infiltrating endometriosis (DIE) with laparoscopic findings.
DESIGN: A prospective study of paired data (Canadian Task Force classification II.1).
SETTING: A tertiary university hospital from November 2014 to November 2015. PATIENTS: A cohort of women awaiting surgery for endometriosis.
INTERVENTIONS: The wall of the rectum and the lower sigmoid colon of the patients were evaluated by 2 TVUSs: the first ultrasound was performed without previous BP, and the second was done after a 3-day low-residue diet and two 250-mL enemas 12 hours and 3 hours before TVUS.
MEASUREMENTS AND MAIN RESULTS: The presence or absence of rectosigmoid nodules visualized by TVUS with and without BP was compared with laparoscopic results. Forty patients with a mean age of 36.8 ± 5.0 years were included in the study. By comparing the surgical findings histologically confirmed (the presence or absence of bowel nodules and localization) with those of the 2 TVUSs with and without BP, the sensitivity, specificity, and Cohen kappa were 100%, 96%, and 0.95 and 73%, 88%, and 0.61, respectively. Laparoscopy showed that up to 37.5% of patients (15/40) presented bowel involvement. Variables were clearly more evaluable with than without BP.
CONCLUSION: TVUS with BP has a higher accuracy than TVUS without BP. BP allows and facilitates the detection of more rectal nodules of DIE in patients with suspected endometriosis and surgical criteria.
Copyright © 2017 American Association of Gynecologic Laparoscopists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bowel endometriosis; Bowel preparation; Deep infiltrating endometriosis; Pelvic pain; Transvaginal ultrasound

Mesh:

Substances:

Year:  2017        PMID: 28673872     DOI: 10.1016/j.jmig.2017.06.024

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  6 in total

1.  Endoscopic Appearance and Management of Recto-Sigmoid Endometriosis: Case Report.

Authors:  Abubakr Adam; Mechu Narayanan; Christine Hachem
Journal:  Gastroenterology Res       Date:  2018-02-08

2.  Accuracy of transvaginal sonography versus magnetic resonance imaging in the diagnosis of rectosigmoid endometriosis: Systematic review and meta-analysis.

Authors:  Ana Paula Carvalhal Moura; Helizabet Salomão Abdalla Ayroza Ribeiro; Wanderley Marques Bernardo; Ricardo Simões; Ulysses S Torres; Giuseppe D'Ippolito; Marc Bazot; Paulo Augusto Ayrosa Galvão Ribeiro
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

Review 3.  Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment.

Authors:  Edgardo Rolla
Journal:  F1000Res       Date:  2019-04-23

4.  Meta-analysis and systematic review to determine the optimal imaging modality for the detection of uterosacral ligaments/torus uterinus, rectovaginal septum and vaginal deep endometriosis.

Authors:  B Gerges; W Li; M Leonardi; B W Mol; G Condous
Journal:  Hum Reprod Open       Date:  2021-11-04

5.  Adenomyosis is an independent risk factor for complications in deep endometriosis laparoscopic surgery.

Authors:  Meritxell Gracia; Cristian de Guirior; Marta Valdés-Bango; Mariona Rius; Cristina Ros; Isabel Matas; Marta Tortajada; María Ángeles Martínez-Zamora; Lara Quintas; Francisco Carmona
Journal:  Sci Rep       Date:  2022-04-30       Impact factor: 4.996

6.  Gynecologic Teleultrasound and COVID-19: Is There a Connection?

Authors:  Ilan E Timor-Tritsch; Steven R Goldstein
Journal:  J Ultrasound Med       Date:  2022-03-21       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.